|
AP1AR expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 6.91757762183443E-12 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.05899741700932E-11 |
| Normal-vs-Stage2 |
3.86439999999766E-05 |
| Normal-vs-Stage3 |
2.20069995560124E-09 |
| Normal-vs-Stage4 |
5.51309997653959E-09 |
| Stage1-vs-Stage2 |
5.940600E-01 |
| Stage1-vs-Stage3 |
5.996400E-01 |
| Stage1-vs-Stage4 |
2.165600E-01 |
| Stage2-vs-Stage3 |
4.419800E-01 |
| Stage2-vs-Stage4 |
2.138400E-01 |
| Stage3-vs-Stage4 |
4.748000E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.83195689121385E-12 |
| Normal-vs-AfricanAmerican |
2.167500E-04 |
| Normal-vs-Asian |
2.70959999992826E-08 |
| Caucasian-vs-AfricanAmerican |
5.693000E-01 |
| Caucasian-vs-Asian |
6.915000E-01 |
| AfricanAmerican-vs-Asian |
4.425000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
9.99977878279878E-13 |
| Normal-vs-Female |
3.37289973728616E-10 |
| Male-vs-Female |
4.469900E-02 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
8.14340039845263E-10 |
| Normal-vs-Age(41-60Yrs) |
1.19020349131915E-11 |
| Normal-vs-Age(61-80Yrs) |
7.86229999993893E-08 |
| Normal-vs-Age(81-100Yrs) |
2.012400E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.293800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.051400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.410600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.502200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.404000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.972800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
9.357000E-01 |
| Classical-VS-Follicular |
5.518600E-01 |
| Classical-VS-Other |
4.953000E-01 |
| Classical-VS-Normal |
2.33949526418087E-11 |
| Tall-VS-Follicular |
7.731800E-01 |
| Tall-VS-Other |
4.861200E-01 |
| Tall-VS-Normal |
4.00259999999708E-05 |
| Follicular-VS-Other |
4.676200E-01 |
| Follicular-VS-Normal |
1.58455000000002E-05 |
| Other-VS-Normal |
2.359000E-03 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.06729983026821E-10 |
| Normal-vs-N1 |
1.623900014458E-09 |
| N0-vs-N1 |
3.107400E-01 |
|
|
